Acclarent Aera: payments to doctors
Payments that named Acclarent Aera as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $791K
- Providers
- 3,882
- Transactions
- 9,532
- Average per transaction
- $83
The per-transaction average — $83 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,882 providers the average total is $204, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Integra Lifesciences Corporation | $573,900 | 72.5% |
| Acclarent, Inc | $176,714 | 22.3% |
| Ethicon Endo-surgery Inc. | $23,364 | 3.0% |
| Biosense Webster, Inc. | $8,708 | 1.1% |
| Medical Device Business Services, Inc. | $7,486 | 0.9% |
| Johnson & Johnson | $809 | 0.1% |
| Actelion Pharmaceuticals US, Inc. | $67 | 0.0% |